Malaysian Regulator Seeks Feedback On Conformity Assessment Expectations
Malaysia’s Medical Device Authority has issued a draft guideline for comment on conformity assessment and what manufacturers must do to demonstrate that their product is safe and performs as intended.
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. In the latest update, see documents posted in May 2017.
New medicines under evaluation at the European Medicines Agency.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.